Clinical Trial Update: A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

View source ↗

Summary

A clinical trial assessing changes in an overactive bladder medication sponsored by Astellas Pharma Inc has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder (OAB) | Status: WITHDRAWN